Shanghai Junshi Biosciences Co Ltd 2025 Annual Report
Company: Shanghai Junshi Biosciences Co Ltd
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report
Pages: 237
The report describes ESG as integrated into strategy, risk management and decision-making, with core topics including governance, compliance, environment, employee rights and accessible healthcare. It highlights over 60 compliance training sessions with full employee coverage and zero incidents of commercial bribery, unfair competition or other violations in 2025. Across its manufacturing sites, the company promoted ISO 14001 certification, while delivering over 300 training sessions and reporting an average of over 100 training hours per employee.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.